AGIO: Agios Pharmaceuticals, Inc.
Performance
AGIO -22.84%
Watchlist
Select an item
Summary
AGIO at a glance
AGIO returned -22.84% over the past year and -7.22% a year over five years. Its worst drop in that year was -50.89%, smaller than 22% of stocks on Redstone, and its Sharpe ratio of 0.12 beats 32% of stocks on Redstone. It pays no dividends.
Current Drawdown
-31.02%
Rolling Volatility
93.27%
Actions
Metrics
Risk Indicators
Alpha0.49%
Beta0.93x
Sharpe0.12
Sortino0.15
Omega1.03
Calmar-0.45
Martin0.30
Profile
About AGIO
Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines.
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $1.9B
- Listed
- Jul 2013
- Employees
- 540
- Headquarters
- Cambridge, MA
- Website
- agios.com
Comparisons